在临床实践环境中，随着艾滋病病毒暴露前预防措施使用的增加，新的艾滋病病毒感染病例未出现增长。
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
作者信息
Volk Jonathan E, Marcus Julia L, Phengrasamy Tony, Blechinger Derek, Nguyen Dong Phuong, Follansbee Stephen, Hare C Bradley
机构信息
Department of Adult and Family Medicine, Kaiser Permanente San Francisco Medical Center.
Division of Research, Kaiser Permanente Northern California, Oakland, California.
出版信息
Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.
Abstract
Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.
摘要
自2012年以来，在一个大型临床实践环境中，针对人类免疫缺陷病毒（HIV）感染的暴露前预防（PrEP）转诊和启动情况急剧增加。尽管PrEP使用者中性传播感染率很高，且有报告称一部分使用者减少了避孕套的使用，但该人群中没有新的HIV感染病例。
相似文献
1
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.
2
Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
Sex Transm Dis. 2018 Dec;45(12):798-802. doi: 10.1097/OLQ.0000000000000880.
3
Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation.
Clin Infect Dis. 2015 Nov 15;61(10):1598-600. doi: 10.1093/cid/civ665. Epub 2015 Aug 13.
4
Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
J Infect Dis. 2018 Jan 30;217(4):617-621. doi: 10.1093/infdis/jix595.
5
Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5. doi: 10.15585/mmwr.mm6446a4.
6
Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia.
Clin Infect Dis. 2015 Nov 15;61(10):1590-7. doi: 10.1093/cid/civ664. Epub 2015 Aug 13.
7
Increasing prevalence of self-reported HIV preexposure prophylaxis use in published surveys: a systematic review and meta-analysis.
AIDS. 2018 Nov 13;32(17):2633-2635. doi: 10.1097/QAD.0000000000001983.
8
Missed Opportunities to Prescribe Preexposure Prophylaxis in South Carolina, 2013-2016.
Clin Infect Dis. 2019 Jan 1;68(1):37-42. doi: 10.1093/cid/ciy441.
9
Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States.
J Med Internet Res. 2016 May 19;18(5):e111. doi: 10.2196/jmir.5713.
10
Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
Clin Infect Dis. 2015 Jun 1;60(11):1728-9. doi: 10.1093/cid/civ129. Epub 2015 Feb 18.
引用本文的文献
1
The Epidemiology of Syphilis Worldwide in the Last Decade.
J Clin Med. 2025 Jul 28;14(15):5308. doi: 10.3390/jcm14155308.
2
Integrated HIV and STIs response: Trends in syphilis incidence and uptake of oral pre-exposure prophylaxis in Zambia.
J Public Health Afr. 2025 Jul 10;16(1):1306. doi: 10.4102/jphia.v16i1.1306. eCollection 2025.
3
Use of cognitive interviews to develop PrEP education for men in New York and Alabama.
Patient Educ Couns. 2025 Sep;138:109221. doi: 10.1016/j.pec.2025.109221. Epub 2025 Jun 6.
4
Factors associated with awareness of and willingness to use PrEP among stable, heterosexual HIV-serodifferent couples in seven African countries, 2019-2022.
J Int AIDS Soc. 2025 Jun;28(6):e26446. doi: 10.1002/jia2.26446.
5
Routine testing for chlamydia and gonorrhea in an HIV preexposure prophylaxis program in Hanoi, Vietnam: implications for low- and middle-income countries.
AIDS. 2025 Jul 15;39(9):1152-1160. doi: 10.1097/QAD.0000000000004203. Epub 2025 Apr 3.
6
Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - CDC Recommendations, United States, 2025.
MMWR Recomm Rep. 2025 May 8;74(1):1-56. doi: 10.15585/mmwr.rr7401a1.
7
Preliminary Outcomes from PrEP Well: A Community-led, Multicomponent HIV Prevention Strategy Implemented in a Transgender Community Health Center.
J Community Health. 2025 Apr 21. doi: 10.1007/s10900-025-01468-4.
8
The mChoice App, an mHealth Tool for the Monitoring of Preexposure Prophylaxis Adherence and Sexual Behaviors in Young Men Who Have Sex With Men: Usability Evaluation.
JMIR Hum Factors. 2025 Feb 28;12:e59780. doi: 10.2196/59780.
9
PrEP Use in a US National Sample of Trans Men and Other Transmasculine People Who Have Sex With Men: A Longitudinal Analysis.
J Acquir Immune Defic Syndr. 2024 Dec 1;97(4):357-363. doi: 10.1097/QAI.0000000000003492.
10
Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis.
JAMA Intern Med. 2025 Mar 1;185(3):273-281. doi: 10.1001/jamainternmed.2024.7186.
本文引用的文献
1
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.
HIV AIDS (Auckl). 2015 Apr 28;7:125-36. doi: 10.2147/HIV.S50025. eCollection 2015.
2
Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
Clin Infect Dis. 2015 Jun 1;60(11):1728-9. doi: 10.1093/cid/civ129. Epub 2015 Feb 18.
3
High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):439-48. doi: 10.1097/QAI.0000000000000479.
4
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.
5
Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.
Clin Infect Dis. 2014 Oct;59(7):1020-6. doi: 10.1093/cid/ciu450. Epub 2014 Jun 13.
6
No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.
PLoS One. 2013 Dec 18;8(12):e81997. doi: 10.1371/journal.pone.0081997. eCollection 2013.
7
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis.
Lancet Infect Dis. 2013 Dec;13(12):1021-8. doi: 10.1016/S1473-3099(13)70226-3. Epub 2013 Oct 17.
8
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.
9
Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion.
J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):537-43. doi: 10.1097/QAI.0b013e3181c3ef29.
10
Risk compensation: the Achilles' heel of innovations in HIV prevention?
BMJ. 2006 Mar 11;332(7541):605-7. doi: 10.1136/bmj.332.7541.605.
Zotero 插件